# Evaluation of the Strategy of "One-stop" Endovascular Treatment for Concomitant Coronary Artery Disease and Aortic Atherosclerotic Disease

> **NCT03563768** · PHASE4 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Disease
- Aortic Atherosclerotic Disease

## Interventions

- **PROCEDURE:** One-stop strategy group

## Key facts

- **NCT ID:** NCT03563768
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563768, "Evaluation of the Strategy of "One-stop" Endovascular Treatment for Concomitant Coronary Artery Disease and Aortic Atherosclerotic Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03563768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*